Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Critical Limb Ischemia Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Critical Limb Ischemia Drugmarket, defines the market attractiveness level of Critical Limb Ischemia Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Critical Limb Ischemia Drug industry, describes the types of Critical Limb Ischemia Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Critical Limb Ischemia Drug market and the development prospects and opportunities of Critical Limb Ischemia Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Critical Limb Ischemia Drug market in Chapter 13.
By Player:
Cynata Therapeutics Ltd
TikoMed AB
Caladrius Biosciences Inc
BiogenCell Ltd
Pluristem Therapeutics Inc
Kasiak Research Pvt Ltd
Symic Biomedical Inc
Neurofx Inc
Hemostemix Inc
US Stem Cell Inc
Nissan Chemical Industries Ltd
Pharmicell Co Ltd
ReNeuron Group Plc
By Type:
HC-016
JVS-100
NFx-101
NK-104 NP
Others
By End-User:
Hospital
Home Care
ASCs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Critical Limb Ischemia Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Critical Limb Ischemia Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Critical Limb Ischemia Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Critical Limb Ischemia Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Critical Limb Ischemia Drug Market Analysis and Outlook to 2022
-
7.1 Global Critical Limb Ischemia Drug Consumption (2017-2022)
-
7.2 United States Critical Limb Ischemia Drug Consumption (2017-2022)
-
7.3 Europe Critical Limb Ischemia Drug Consumption (2017-2022)
-
7.4 China Critical Limb Ischemia Drug Consumption (2017-2022)
-
7.5 Japan Critical Limb Ischemia Drug Consumption (2017-2022)
-
7.6 India Critical Limb Ischemia Drug Consumption (2017-2022)
-
7.7 South Korea Critical Limb Ischemia Drug Consumption (2017-2022)
8 Region and Country-wise Critical Limb Ischemia Drug Market Analysis and Outlook to 2028
-
8.1 Global Critical Limb Ischemia Drug Consumption Forecast (2022-2028)
-
8.2 United States Critical Limb Ischemia Drug Consumption Forecast (2022-2028)
-
8.3 Europe Critical Limb Ischemia Drug Consumption Forecast (2022-2028)
-
8.4 China Critical Limb Ischemia Drug Consumption Forecast (2022-2028)
-
8.5 Japan Critical Limb Ischemia Drug Consumption Forecast (2022-2028)
-
8.6 India Critical Limb Ischemia Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Critical Limb Ischemia Drug Consumption Forecast (2022-2028)
9 Global Critical Limb Ischemia Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Critical Limb Ischemia Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HC-016 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global JVS-100 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NFx-101 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global NK-104 NP Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Critical Limb Ischemia Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Home Care Consumption and Growth Rate (2017-2022)
-
9.2.3 Global ASCs Consumption and Growth Rate (2017-2022)
10 Global Critical Limb Ischemia Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Critical Limb Ischemia Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global HC-016 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global JVS-100 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global NFx-101 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global NK-104 NP Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Critical Limb Ischemia Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global ASCs Consumption Forecast and Growth Rate (2022-2028)
11 Global Critical Limb Ischemia Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Critical Limb Ischemia Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Critical Limb Ischemia Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Critical Limb Ischemia Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Critical Limb Ischemia Drug Market Competitive Analysis
-
14.1 Cynata Therapeutics Ltd
-
14.1.1 Cynata Therapeutics Ltd Company Details
-
14.1.2 Cynata Therapeutics Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Cynata Therapeutics Ltd Critical Limb Ischemia Drug Product and Service
-
14.2 TikoMed AB
-
14.2.1 TikoMed AB Company Details
-
14.2.2 TikoMed AB Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 TikoMed AB Critical Limb Ischemia Drug Product and Service
-
14.3 Caladrius Biosciences Inc
-
14.3.1 Caladrius Biosciences Inc Company Details
-
14.3.2 Caladrius Biosciences Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Caladrius Biosciences Inc Critical Limb Ischemia Drug Product and Service
-
14.4 BiogenCell Ltd
-
14.4.1 BiogenCell Ltd Company Details
-
14.4.2 BiogenCell Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 BiogenCell Ltd Critical Limb Ischemia Drug Product and Service
-
14.5 Pluristem Therapeutics Inc
-
14.5.1 Pluristem Therapeutics Inc Company Details
-
14.5.2 Pluristem Therapeutics Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pluristem Therapeutics Inc Critical Limb Ischemia Drug Product and Service
-
14.6 Kasiak Research Pvt Ltd
-
14.6.1 Kasiak Research Pvt Ltd Company Details
-
14.6.2 Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Product and Service
-
14.7 Symic Biomedical Inc
-
14.7.1 Symic Biomedical Inc Company Details
-
14.7.2 Symic Biomedical Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Symic Biomedical Inc Critical Limb Ischemia Drug Product and Service
-
14.8 Neurofx Inc
-
14.8.1 Neurofx Inc Company Details
-
14.8.2 Neurofx Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Neurofx Inc Critical Limb Ischemia Drug Product and Service
-
14.9 Hemostemix Inc
-
14.9.1 Hemostemix Inc Company Details
-
14.9.2 Hemostemix Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Hemostemix Inc Critical Limb Ischemia Drug Product and Service
-
14.10 US Stem Cell Inc
-
14.10.1 US Stem Cell Inc Company Details
-
14.10.2 US Stem Cell Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 US Stem Cell Inc Critical Limb Ischemia Drug Product and Service
-
14.11 Nissan Chemical Industries Ltd
-
14.11.1 Nissan Chemical Industries Ltd Company Details
-
14.11.2 Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Product and Service
-
14.12 Pharmicell Co Ltd
-
14.12.1 Pharmicell Co Ltd Company Details
-
14.12.2 Pharmicell Co Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pharmicell Co Ltd Critical Limb Ischemia Drug Product and Service
-
14.13 ReNeuron Group Plc
-
14.13.1 ReNeuron Group Plc Company Details
-
14.13.2 ReNeuron Group Plc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 ReNeuron Group Plc Critical Limb Ischemia Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Critical Limb Ischemia Drug
-
Figure Critical Limb Ischemia Drug Picture
-
Table Global Critical Limb Ischemia Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Critical Limb Ischemia Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Critical Limb Ischemia Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Critical Limb Ischemia Drug Consumption by Country (2017-2022)
-
Figure United States Critical Limb Ischemia Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Critical Limb Ischemia Drug Consumption and Growth Rate (2017-2022)
-
Figure China Critical Limb Ischemia Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Critical Limb Ischemia Drug Consumption and Growth Rate (2017-2022)
-
Figure India Critical Limb Ischemia Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Critical Limb Ischemia Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Critical Limb Ischemia Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Critical Limb Ischemia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Critical Limb Ischemia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Critical Limb Ischemia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Critical Limb Ischemia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Critical Limb Ischemia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Critical Limb Ischemia Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HC-016 Consumption and Growth Rate (2017-2022)
-
Figure Global JVS-100 Consumption and Growth Rate (2017-2022)
-
Figure Global NFx-101 Consumption and Growth Rate (2017-2022)
-
Figure Global NK-104 NP Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global ASCs Consumption and Growth Rate (2017-2022)
-
Figure Global HC-016 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global JVS-100 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NFx-101 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NK-104 NP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ASCs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Critical Limb Ischemia Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Critical Limb Ischemia Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Cynata Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table Cynata Therapeutics Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cynata Therapeutics Ltd Critical Limb Ischemia Drug Product and Service
-
Table TikoMed AB (Foundation Year, Company Profile and etc.)
-
Table TikoMed AB Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TikoMed AB Critical Limb Ischemia Drug Product and Service
-
Table Caladrius Biosciences Inc (Foundation Year, Company Profile and etc.)
-
Table Caladrius Biosciences Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Caladrius Biosciences Inc Critical Limb Ischemia Drug Product and Service
-
Table BiogenCell Ltd (Foundation Year, Company Profile and etc.)
-
Table BiogenCell Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table BiogenCell Ltd Critical Limb Ischemia Drug Product and Service
-
Table Pluristem Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Pluristem Therapeutics Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pluristem Therapeutics Inc Critical Limb Ischemia Drug Product and Service
-
Table Kasiak Research Pvt Ltd (Foundation Year, Company Profile and etc.)
-
Table Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kasiak Research Pvt Ltd Critical Limb Ischemia Drug Product and Service
-
Table Symic Biomedical Inc (Foundation Year, Company Profile and etc.)
-
Table Symic Biomedical Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Symic Biomedical Inc Critical Limb Ischemia Drug Product and Service
-
Table Neurofx Inc (Foundation Year, Company Profile and etc.)
-
Table Neurofx Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurofx Inc Critical Limb Ischemia Drug Product and Service
-
Table Hemostemix Inc (Foundation Year, Company Profile and etc.)
-
Table Hemostemix Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hemostemix Inc Critical Limb Ischemia Drug Product and Service
-
Table US Stem Cell Inc (Foundation Year, Company Profile and etc.)
-
Table US Stem Cell Inc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table US Stem Cell Inc Critical Limb Ischemia Drug Product and Service
-
Table Nissan Chemical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nissan Chemical Industries Ltd Critical Limb Ischemia Drug Product and Service
-
Table Pharmicell Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Pharmicell Co Ltd Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmicell Co Ltd Critical Limb Ischemia Drug Product and Service
-
Table ReNeuron Group Plc (Foundation Year, Company Profile and etc.)
-
Table ReNeuron Group Plc Critical Limb Ischemia Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ReNeuron Group Plc Critical Limb Ischemia Drug Product and Service
-
